BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

Invicta Diagnostic Ltd. Share Price

NSE
BSE

NSE : INVICTA

BSE : 0

Sector : Healthcare

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Day's Range

Low

₹61.20

High

₹64.00

Price Summary

Previous Close ₹61.20
Day's Range ₹61.20 - ₹64.00
Open ₹62.95
52 Week Range ₹58.10 - ₹105.00
Volume 49,600
Market Cap ₹0.00

Stocks Summary

Trade Value ( ₹ in Lacs) 30.36
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 0.00
Price/Earning (TTM) 16.46
TTM EPS (₹) 3.90
P/E Ratio 0.00
Book Value(₹) 1.57
PAT Margin (%) 16.38
Face Value (₹) 10.00
ROCE(%) 42.85

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales N/A 162.7
Expenses N/A N/A
PBT N/A 66.84
Operating profit N/A 0.0
Net profit N/A 52.28

Shareholding Pattern

Promoters (% Holding)

66.70%

Mutual funds (% Holding)

0.00%

Non-Institution (% Holding)

24.81%

FI/Banks/Insurance (% Holding)

0.00%

Government (% Holding)

0.00%

FII

4.20%

About Invicta Diagnostic Ltd.

Founded 2023
NSE Symbol INVICTA

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd. 4,29,145.05 1,780.50 1,548.00 - 1,548.00
Divi's Laboratories Ltd. 1,72,988.62 6,758.00 5,636.50 - 5,636.50
Torrent Pharmaceuticals Ltd. 1,49,322.13 4,466.30 3,140.10 - 3,140.10
Apollo Hospitals Enterprise Ltd. 1,20,125.61 8,525.60 6,696.50 - 6,696.50
Cipla Ltd. 1,12,149.13 1,376.75 1,165.70 - 1,165.70
Zydus Lifesciences Ltd. 1,09,422.92 1,106.10 835.50 - 835.50
Dr. Reddy's Laboratories Ltd. 1,06,482.91 1,268.75 1,148.40 - 1,148.40
Lupin Ltd. 1,02,996.20 2,257.00 1,836.80 - 1,836.80
Max Healthcare Institute Ltd. 97,913.19 1,003.25 903.00 - 903.00
Mankind Pharma Ltd. 97,382.57 2,390.00 1,909.70 - 1,909.70
no-content No Records Found

Latest News

Jun
9
2026
EQUITY Posted on Jun 9th 2026

Glenmark Pharmaceuticals informs about investor presentation

Glenmark Pharmaceuticals has informed that it attached Investor Presentation to be made at Glenmark Pharmaceuticals Investor Day 2026 today.
The above information is a part of company’s filings submitted to BSE.
Read More
Jun
9
2026
EQUITY Posted on Jun 9th 2026

Anlon Healthcare informs about conference call

Anlon Healthcare has informed that the transcript of the Earnings Conference call held on Wednesday, June 03, 2026 at 04:00 PM (IST) is attached. This will also be hosted on the Company’s website at https://www.anlon.in/reports.php?subid=15&name=Investor-Meet.
The above information is a part of company’s filings submitted to BSE.
Read More
Jun
9
2026
EQUITY Posted on Jun 9th 2026

Ipca Laboratories informs about newspaper publication

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Ipca Laboratories has enclosed copies of the Newspaper Notice (Business Standard & Navshakti), issued to the shareholders of the Company in respect of transfer of equity shares to the IEPF Authority in accordance with the requirements of Section 124(6) of the Companies Act, 2013 read with Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016.
The above information is a part of company’s filings submitted to BSE.  
Read More
Jun
9
2026
EQUITY Posted on Jun 9th 2026

Kerala Ayurveda informs about change in management

Kerala Ayurveda has informed that Samir Dhawan (DIN: 01178691), an Independent Director of the Company had resigned from the Board of the Company with effect from the close of business hours of June 09, 2026 vide his resignation letter dated June 09, 2026. In compliance with Regulation 30 read with Clause 7B of Para A of Part A of Schedule III of the SEBI Listing Regulations and SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, is enclosed as ‘Annexure-A’. The resignation letter confirming that there are no other material reasons for his resignation is enclosed as ‘Annexure B’. The same is also being made available on the Company’s website at: https://keralaayurveda.com/pages/investors.
The above information is a part of company’s filings submitted to BSE.
Read More
Jun
9
2026
EQUITY Posted on Jun 9th 2026

Makers Laboratories informs about newspaper publication

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Makers Laboratories has enclosed notice published in the Newspaper (published in Business Standard and Navshakti), issued to the shareholders of the Company in respect of transfer of equity shares to the IEPF Authority in accordance with the requirements of Section 124(6) of the Companies Act, 2013 read with Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016.
The above information is a part of company’s filings submitted to BSE.  
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Invicta Diagnostic Ltd. ?

The current share price of Invicta Diagnostic Ltd. is ₹61.20 as of 2026-06-09.

The market capitalisation of Invicta Diagnostic Ltd. is ₹80.77 as of 2026-06-08.

The 1-year return of Invicta Diagnostic Ltd. is 0.00% as of 2026-06-09.

The P/E ratio of Invicta Diagnostic Ltd. is 0.00 as of 2026-06-09.

The 52-week high and low of Invicta Diagnostic Ltd. are ₹105.00 and ₹58.10, respectively, as of 2026-06-09.

The dividend yield of Invicta Diagnostic Ltd. is 0.0% as of2026-06-08.

You can buy Invicta Diagnostic Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Invicta Diagnostic Ltd. is .

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore